G.R. Kerr

4.8k total citations
97 papers, 3.2k citations indexed

About

G.R. Kerr is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G.R. Kerr has authored 97 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 31 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G.R. Kerr's work include Breast Cancer Treatment Studies (27 papers), Global Cancer Incidence and Screening (12 papers) and Head and Neck Cancer Studies (12 papers). G.R. Kerr is often cited by papers focused on Breast Cancer Treatment Studies (27 papers), Global Cancer Incidence and Screening (12 papers) and Head and Neck Cancer Studies (12 papers). G.R. Kerr collaborates with scholars based in United Kingdom, Australia and Canada. G.R. Kerr's co-authors include W. Duncan, Stuart Pocock, W Jack, A.O. Langlands, Sheila M. Gore, S.J. Arnott, David Cameron, S M Gore, R.H. MacDougall and A. Gregor and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

G.R. Kerr

96 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.R. Kerr United Kingdom 31 1.2k 1.1k 1.1k 642 411 97 3.2k
Saveli Goldberg United States 33 999 0.9× 984 0.9× 1.3k 1.2× 752 1.2× 698 1.7× 108 3.1k
Harald Anderson Sweden 34 639 0.6× 1.3k 1.1× 956 0.9× 770 1.2× 970 2.4× 79 4.1k
Clive Harmer United Kingdom 42 1.7k 1.5× 1.2k 1.1× 1.2k 1.1× 368 0.6× 528 1.3× 138 4.9k
Samuel G. Taylor United States 27 620 0.5× 1.4k 1.3× 1.3k 1.2× 634 1.0× 358 0.9× 77 2.9k
Matthew Koshy United States 36 781 0.7× 1.2k 1.0× 1.7k 1.5× 418 0.7× 569 1.4× 125 4.3k
A. Kramar France 27 1.4k 1.2× 940 0.8× 646 0.6× 450 0.7× 290 0.7× 88 2.8k
P. Romestaing France 32 1.8k 1.5× 1.8k 1.6× 973 0.9× 1.1k 1.7× 582 1.4× 142 3.8k
Pascal Piedbois France 31 1.0k 0.9× 2.5k 2.2× 1.2k 1.1× 359 0.6× 553 1.3× 101 3.7k
Diana Fischer United States 28 613 0.5× 1.1k 0.9× 569 0.5× 1.1k 1.8× 998 2.4× 65 3.0k
Jean B. Owen United States 27 1.0k 0.9× 630 0.6× 987 0.9× 467 0.7× 243 0.6× 108 2.6k

Countries citing papers authored by G.R. Kerr

Since Specialization
Citations

This map shows the geographic impact of G.R. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.R. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.R. Kerr more than expected).

Fields of papers citing papers by G.R. Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.R. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.R. Kerr. The network helps show where G.R. Kerr may publish in the future.

Co-authorship network of co-authors of G.R. Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of G.R. Kerr. A scholar is included among the top collaborators of G.R. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.R. Kerr. G.R. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dixon, J. Michael, et al.. (2016). A study of margin width and local recurrence in breast conserving therapy for invasive breast cancer. European Journal of Surgical Oncology. 42(5). 657–664. 12 indexed citations
2.
Ramsey, Scott D., G.R. Kerr, G.C.W. Howard, & Roland Donat. (2013). Orchidectomy after Primary Chemotherapy for Metastatic Testicular Cancer. Urologia Internationalis. 91(4). 439–444.
3.
Spears, Melanie, Jeremy Thomas, G.R. Kerr, et al.. (2012). Expression of activated type I receptor tyrosine kinases in early breast cancer. Breast Cancer Research and Treatment. 134(2). 701–708. 3 indexed citations
4.
Junor, Elizabeth, G.R. Kerr, Anca Oniscu, et al.. (2011). Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx. British Journal of Cancer. 106(2). 358–365. 29 indexed citations
5.
Dixon, J. Michael, Lorna Renshaw, E. Jane Macaskill, et al.. (2008). Increase in response rate by prolonged treatment with neoadjuvant letrozole. Breast Cancer Research and Treatment. 113(1). 145–151. 80 indexed citations
6.
Erridge, Sara, et al.. (2007). Improving Outcomes for Limited Stage Small Cell Lung Cancer Patients in Scotland with Concomitant Chemoradiation. Clinical Oncology. 19(3). 188–193. 3 indexed citations
7.
Erridge, Sara, et al.. (2002). The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma. Radiotherapy and Oncology. 63(1). 59–66. 12 indexed citations
8.
Robertson, Chris, J.H. Hendry, Stephen A. Roberts, et al.. (1998). Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. International Journal of Radiation Oncology*Biology*Physics. 40(2). 319–329. 117 indexed citations
9.
El-Galley, Rizk, G.C.W. Howard, Simon Hawkyard, et al.. (1995). Radical radiotherapy for localized adenocarcinoma of the prostate. A report of 191 cases. British Journal of Urology. 75(1). 38–43. 8 indexed citations
10.
Bliss, Peter, G.R. Kerr, & A. Gregor. (1994). Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962–1990. Clinical Oncology. 6(6). 361–363. 60 indexed citations
11.
AL‐NAFUSSI, A.I., et al.. (1993). The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in the uterine cervix and cervical squamous neoplasia. International Journal of Gynecological Cancer. 3(3). 154–158. 13 indexed citations
12.
Hardman, P.D.J., et al.. (1992). The value of internal fixation and radiotherapy in the management of upper and lower limb bone metastases. Clinical Oncology. 4(4). 244–248. 17 indexed citations
13.
Kunkler, I.H., et al.. (1991). The value of follow-up in stage II carcinoma of the cervix. Clinical Oncology. 3(1). 28–31. 12 indexed citations
14.
Kerr, G.R., et al.. (1989). Radical radiotherapy for bronchogenic carcinoma: Five year survival rates. Clinical Oncology. 1(2). 80–85. 14 indexed citations
15.
Quilty, P.M. & G.R. Kerr. (1987). Bladder cancer following low or high dose pelvic irradiation. Clinical Radiology. 38(6). 583–585. 17 indexed citations
16.
Duncan, W., S.J. Arnott, W Jack, et al.. (1987). Results of two randomised clinical trials of neutron therapy in rectal adenocarcinoma. Radiotherapy and Oncology. 8(3). 191–198. 23 indexed citations
17.
Duncan, W., J. McLelland, W Jack, et al.. (1986). The results of a randomised trial of mixed-schedule (neutron/photon) irradiation in the treatment of supratentorial Grade III and Grade IV astrocytoma. British Journal of Radiology. 59(700). 379–383. 25 indexed citations
18.
Dewar, J & G.R. Kerr. (1985). Value of routine follow up of women treated for early carcinoma of the breast.. BMJ. 291(6507). 1464–1467. 78 indexed citations
19.
Langlands, A.O., Stuart Pocock, G.R. Kerr, & S M Gore. (1979). Long-term survival of patients with breast cancer: a study of the curability of the disease.. BMJ. 2(6200). 1247–1251. 186 indexed citations
20.
Kerr, G.R., et al.. (1976). The curability of breast cancer.. BMJ. 2(6039). 781–783. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026